1. Celgene wins FDA approval for drug key to Bristol buyout — FDA approves TAVR valves for low-risk patients — Warning signs always there for the Novartis-AveXis deal — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

Abandon Ship! Comp Plan SUCKS!

Discussion in 'Sage Therapeutics' started by anonymous, Jun 11, 2019 at 2:31 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest


    Thats just it. You must not work here because you would know.
     
  2. anonymous

    anonymous Guest

    There are none. We are expanding not contracting.
     
  3. anonymous

    anonymous Guest

    This is not terribly encouraging. Anything changed or improved since you posted this?
     
  4. anonymous

    anonymous Guest

    This is no where near the truth- also anyone that says they speak for 80% of the sales force is delusional. I can say the the people I’m close with are happy and engaged. There is pressure now with the launch, but that is everywhere- we are in sales and that’s to be expected with a launch. This product is complicated but it’s important and the company pipeline is unbelievable.
     
  5. anonymous

    anonymous Guest

    This statement is a COMPLETE LIE. You are delusion. No one trust the above comment. There is one company (which I will not mention) that is looking for a sales force and the recruiting company has stated several applicants are from Sage. SO many are looking to get out right now.
     
  6. anonymous

    anonymous Guest

    several applicants huh? Must mean everyone is jumping ship. Way to generalize all over the place.
     
  7. anonymous

    anonymous Guest

    This might be the most overhyped organization I’ve seen in my 30 year career. Not to mention this totally fabricated ‘new market!’ Good luck paying the investors back. Meanwhile the CEO hear keeps racking up awards.
    #smokeandmirrors